OCOG | HOME

Evaluate improving the outcome of radiation therapy

We are using innovative technology to deliver higher dose radiation regimens in shorter periods of time while at the same time minimizing toxicity to surrounding normal tissue. We are studying novel drugs that can make the tumor more sensitive to radiation.

Evaluate drugs that are used in the fight against cancer

Strategies that we use include studying novel agents that attack molecular targets within the cancer cell, optimizing existing chemotherapy or endocrine therapy by studying different sequences or combinations of drugs, and identifying better agents to manage the side effects of cancer e.g. anemia and thrombosis.

Evaluate how best to incorporate new expensive technology into clinical practice

Studies are conducted evaluating new imaging technologies. Multidisciplinary collaborations have been established between clinicians, methodologists, imaging physicians, physicists and economists.

Improve the quality of care for the cancer patients

Studies are being done to examine improving communication between patients and physicians, how best to follow well cancer survivors, and how best to manage lymphedema.

About Us

The Ontario Clinical Oncology Group (OCOG)

is an academic-based, clinical trials development and coordination organization. OCOG works with investigators to conceive, design, coordinate, conduct, analyze and publish clinical trials with a focus primarily on cancer research (with a secondary interest in venous thrombosis). Together with a network of local, provincial, national and...

The Team

Jim Wright

is an Associate Professor in the Department of Oncology at McMaster University, Hamilton, Ontario, Canada. He is a practicing radiation oncologist with clinical expertise in the treatment of head and neck and lung cancers. Dr. Wright received his medical degree...

Clinical Trials

C-TRACT

Chronic Venous Thrombosis: Relief with...

CYTOSHRINK

Cytoreductive Stereotactic Hypofractionated Radiotherapy with ...

RHEAL

Randomized Trial of Hypofractionated LocoRegional Radiotherapy in Breast ...